ASAN insider filing: 14,500 founder shares to sell on 10/10/2025
Rhea-AI Filing Summary
Form 144 notice: A holder linked to early founders proposes to sell 14,500 shares of common stock on 10/10/2025, with an aggregate market value of $220,255.00. The shares were acquired as founders shares on 02/04/2009. The filing names Morgan Stanley Smith Barney LLC as the broker and lists total shares outstanding as 156,685,245, which frames the proposed sale as immaterial to total supply.
The filing also discloses a series of prior Rule 10b5-1 sales attributed to Justin Rosenstein across 07/18/2025–10/09/2025, with multiple transactions and gross proceeds reported (individual proceeds listed). The filer attests there is no undisclosed material adverse information and notes compliance language about Rule 10b5-1 plans.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine founder sale under Rule 144 with prior 10b5-1 activity disclosed.
The filing documents a proposed sale of 14,500 founder shares acquired on 02/04/2009, using Morgan Stanley as broker and targeting 10/10/2025 for execution. The size ($220,255) is small relative to the reported 156,685,245 outstanding shares, indicating limited direct market impact.
Multiple prior Rule 10b5-1 sales for Justin Rosenstein between 07/18/2025 and 10/09/2025 are listed with reported gross proceeds, demonstrating ongoing prearranged sales. Key items to watch near term are the actual trade execution on 10/10/2025 and any subsequent Form 4 filings that report the post-sale beneficial ownership.